Physician profile
Gregory Thompson
NPI 1750512349
$755.23
in general payments reported to CMS, 2019-2025
14 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $411 · 2021: $57.37 · 2023: $13.56 · 2024: $15.91 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Varian Medical Systems, INC. | $465.56 | 2019-2020 | |
| Elekta, INC. | $39.71 | 2019 | |
| Janssen Biotech, INC. | $37.05 | 2021-2025 | Talvey, Darzalex |
| Gilead Sciences, INC. | $32.21 | 2025 | |
| Jazz Pharmaceuticals INC. | $31.08 | 2021 | |
| Daiichi Sankyo INC. | $27.17 | 2025 | |
| Stemline Therapeutics INC. | $19.99 | 2025 | Orserdu |
| Merck Sharp & Dohme LLC | $19.31 | 2025 | Lynparza, Keytruda |
| Immunitybio, INC. | $15.91 | 2024 | |
| Ferring Pharmaceuticals INC. | $14.84 | 2025 | Adstiladrin |
| Agios Pharmaceuticals, INC. | $14.00 | 2019 | |
| Astellas Pharma US INC | $13.56 | 2023 | Padcev |
| Seagen INC. | $12.58 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.